Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Ras Gene02:38

The Ras Gene

7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colony-stimulating factor 3 as a key mediator in the progression of idiopathic pulmonary fibrosis: a novel therapeutic target.

Signal transduction and targeted therapy·2025
Same author

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.

Molecular cancer·2024
Same author

A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023
Same author

Human Neuralized is a novel tumour suppressor targeting Wnt/β-catenin signalling in colon cancer.

EMBO reports·2023
Same author

Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor.

Yonsei medical journal·2023
Same author

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer.

Cell death discovery·2022
Same journal

Mutation detection in women diagnosed with endometrial cancer: a next-generation sequencing analysis.

Molecular & cellular oncology·2026
Same journal

Evolutionary perspectives on endometrial cancer: antagonistic pleiotropy.

Molecular & cellular oncology·2026
Same journal

mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting.

Molecular & cellular oncology·2026
Same journal

Exploration of the diagnostic and therapeutic potential of the nucleocytoplasmic shuttling protein TMUB1 by inducing G0/G1 cell cycle arrest in ovarian cancer.

Molecular & cellular oncology·2026
Same journal

The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumors.

Molecular & cellular oncology·2026
Same journal

Lactylation-related genes signature panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization.

Molecular & cellular oncology·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

10.0K

KRAS-driven ROS promote malignant transformation.

Yongjoon Suh1, Su-Jae Lee1

  • 1Department of Life Science; Research Institute for Natural Sciences; Hanyang University ; Seoul, Korea.

Molecular & Cellular Oncology
|June 17, 2016
PubMed
Summary
This summary is machine-generated.

Kirsten rat sarcoma viral oncogene homolog (KRAS) drives malignant transformation by increasing reactive oxygen species (ROS). This study identified the specific KRAS signaling pathway responsible for this ROS elevation and subsequent cellular changes.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

15.9K

Related Experiment Videos

Last Updated: Mar 19, 2026

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

10.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

15.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • The precise mechanisms of Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven cellular transformation are not fully understood due to the intricate network of its downstream effectors.
  • KRAS is a key oncogene frequently mutated in various human cancers, highlighting its critical role in tumorigenesis.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which KRAS promotes cellular transformation.
  • To identify the specific signaling pathway responsible for KRAS-mediated reactive oxygen species (ROS) production and its role in malignant transformation.

Main Methods:

  • The study investigated the signaling cascade downstream of KRAS.
  • Researchers analyzed the role of reactive oxygen species (ROS) in KRAS-driven cellular transformation.
  • Specific molecular interactions within the identified pathway were examined.

Main Results:

  • KRAS activation leads to increased levels of reactive oxygen species (ROS) within cells.
  • The identified signaling cascade is KRAS/p38/PDPK1/PKCδ/p47(phox)/NOX1.
  • Elevated ROS mediated by this pathway are crucial for KRAS-driven malignant transformation.

Conclusions:

  • Reactive oxygen species (ROS) play a critical role in KRAS-driven malignant transformation.
  • The identified KRAS/p38/PDPK1/PKCδ/p47(phox)/NOX1 signaling cascade provides a new molecular framework for understanding KRAS oncogenesis.